MACTER Stock Overview
Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Macter International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨98.33 |
| 52 Week High | PK₨106.30 |
| 52 Week Low | PK₨75.75 |
| Beta | 0 |
| 1 Month Change | 3.51% |
| 3 Month Change | n/a |
| 1 Year Change | 15.53% |
| 3 Year Change | -29.76% |
| 5 Year Change | 18.47% |
| Change since IPO | 14.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| MACTER | PK Life Sciences | PK Market | |
|---|---|---|---|
| 7D | -1.7% | -4.9% | 0.2% |
| 1Y | 15.5% | -34.0% | 57.6% |
Return vs Industry: MACTER exceeded the PK Life Sciences industry which returned -35.7% over the past year.
Return vs Market: MACTER underperformed the PK Market which returned 58% over the past year.
Price Volatility
| MACTER volatility | |
|---|---|
| MACTER Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 8.0% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PK Market | 8.4% |
| 10% least volatile stocks in PK Market | 3.3% |
Stable Share Price: MACTER has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MACTER's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Asif Misbah | www.macter.com |
Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. The company offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders; injections, including sterile liquid vials, sterile liquid ampoules, and sterile dry powders; and ointments and creams, drops, and inhalers.
Macter International Limited Fundamentals Summary
| MACTER fundamental statistics | |
|---|---|
| Market cap | PK₨4.87b |
| Earnings (TTM) | PK₨0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MACTER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MACTER income statement (TTM) | |
|---|---|
| Revenue | PK₨0 |
| Cost of Revenue | PK₨0 |
| Gross Profit | PK₨0 |
| Other Expenses | PK₨0 |
| Earnings | PK₨0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MACTER perform over the long term?
See historical performance and comparison